Canton Strategic Holdings (CNTN) Operating Income (2021 - 2026)
Canton Strategic Holdings posted quarterly Operating Income of -$36.9 million for Q1 2026, down 1347.71% year-on-year from $3.0 million in Q1 2025, and down 1474.42% on a QoQ basis from -$2.3 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 6 years of Operating Income data on file, last reported at -$36.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 1347.71% year-over-year to -$36.9 million; the trailing twelve-month figure through Mar 2026 stood at -$43.2 million (down 242.52% YoY), and the FY2025 full-year result was -$8.8 million, up 28.7% from the prior year.
- Operating Income for Q1 2026 stood at -$36.9 million, down from -$2.3 million in the prior quarter.
- Across five years, Operating Income topped out at -$1.4 million in Q1 2022 and bottomed at -$36.9 million in Q1 2026.
- The 5-year median for Operating Income is -$2.3 million (2024), against an average of -$4.4 million.
- The widest annual swing landed in 2022, when Operating Income plunged 1638.74%; it then jumped 45.84% in 2025.
- A 5-year view of Operating Income shows it stood at -$1.8 million in 2022, then tumbled by 43.29% to -$2.5 million in 2023, then sank by 50.67% to -$3.8 million in 2024, then surged by 38.6% to -$2.3 million in 2025, then plunged by 1474.42% to -$36.9 million in 2026.
- The last three Operating Income figures came in at -$36.9 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | -36.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.87 Mn |
| Dec 31, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -1.85 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -3.81 Mn |
| Sep 30, 2024 | -3.87 Mn |
| Jun 30, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -2.53 Mn |
| Sep 30, 2023 | -1.85 Mn |
| Jun 30, 2023 | -2.36 Mn |
| Mar 31, 2023 | -2.71 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Sep 30, 2022 | -2.13 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | -1.35 Mn |
| Dec 31, 2021 | -101,593.00 |
| Sep 30, 2021 | -541,113.00 |
| Jun 30, 2021 | -1.10 Mn |
| Mar 31, 2021 | -1.47 Mn |